GlassScriptPhysician profile
Haley C White
NPI 1356753347
$8,854.57
in general payments reported to CMS, 2019-2025
43 companies · $1,284 in 2025
The $1,284 reported for 2025 was more than what 90% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,819 · 2022: $2,394 · 2023: $2,016 · 2024: $1,342 · 2025: $1,284.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,641.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,641.22 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $1,647.84 | 2021-2025 | Ozempic, Wegovy, Rybelsus |
| Abbvie INC. | $995.57 | 2021-2025 | |
| Astrazeneca Pharmaceuticals LP | $531.03 | 2021-2025 | Breztri, Airsupra, Farxiga |
| Bayer Healthcare Pharmaceuticals INC. | $496.82 | 2022-2025 | |
| Lilly USA, LLC | $490.57 | 2021-2025 | Mounjaro, Jardiance, Emgality |
| Pfizer INC. | $457.98 | 2021-2025 | |
| Glaxosmithkline, LLC. | $414.19 | 2021-2025 | Trelegy Ellipta, Arexvy, Shingrix |
| Amgen INC. | $390.04 | 2021-2025 | Repatha, Otezla, Evenity |
| Corium, LLC | $355.30 | 2022-2025 | Azstarys |
| Merck Sharp & Dohme LLC | $346.74 | 2021-2025 | Verquvo, Belsomra, Gardasil 9 |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $254.86 | 2021-2025 | Xifaxan, Relistor |
| Novartis Pharmaceuticals Corporation | $209.73 | 2021-2023 | |
| Sanofi-Aventis U.S. LLC | $209.45 | 2021-2022 | |
| Otsuka America Pharmaceutical, INC. | $180.22 | 2023-2025 | Rexulti |
| Boehringer Ingelheim Pharmaceuticals, INC. | $163.32 | 2021-2024 | Jardiance |
Show all 43 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Haley White listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.